CL
Another investor hits the brakes
Freestone Capital Holdings quietly cut its Colgate-Palmolive position by a whopping 80.9%, unloading 32,395 shares and leaving itself with 7,628 shares worth about $603,000 at quarter end. That’s the kind of move that makes you squint a little at the 13F and ask: was this portfolio housekeeping, or a real loss of enthusiasm?
Why investors care
On its own, one fund trimming a consumer staples name isn’t a thunderclap. But it does land in a week where Colgate is already getting plenty of attention: insiders have been net sellers over the last 90 days, analysts still sit at a "Moderate Buy," and the company has been leaning on shareholder-friendly moves like a fresh dividend bump to $0.53 a share.
The bigger backdrop
Colgate’s core business is still doing the boring-but-beautiful thing investors usually like: it posted quarterly EPS of $0.95 on revenue of $5.23 billion, both ahead of expectations, and revenue rose 5.8% year over year. That’s not exactly rocket fuel, but for a household-products company, steady beats are the whole game.
Big picture
This filing doesn’t scream panic. But it does remind you that even a defensive dividend name can have its owners drifting around the pool deck. In a market obsessed with momentum, Colgate is still winning by being the reliable person at the party who brought extra snacks — even if a few guests are heading for the door.